Leukemia Market Research Reports
To refine your search by industry, market, geographic region, country or price, use Advanced Search or contact Client Services for assistance.
- 1
- 2
-
-
Report Title
Published
Price
-
October 31, 2022$2,000.00
-
June 10, 2022$2,000.00
-
June 2, 2022$2,500.00
-
May 31, 2022$2,500.00
-
May 15, 2022$2,500.00
-
May 11, 2022$2,000.00
-
April 29, 2022$2,000.00
-
April 23, 2022$2,000.00
-
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) (Oncology) - Drugs in Development, 2021January 8, 2022$2,500.00
-
August 1, 2021$2,500.00
-
May 10, 2021$4,000.00
-
May 10, 2021$1,800.00
-
May 10, 2021$1,800.00
-
October 2, 2020$3,500.00
-
April 30, 2020$2,000.00
-
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2020January 15, 2020$2,500.00
-
November 18, 2019$2,000.00
-
April 1, 2019$6,250.00
-
March 26, 2019$3,500.00
-
November 20, 2018$3,995.00
-
October 25, 2018$2,500.00
-
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H2, 2018October 25, 2018$2,500.00
-
October 25, 2018$2,500.00
-
October 16, 2018$2,000.00
-
August 31, 2018$2,500.00
- 1
- 2
-